# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001213900-21-047306
Filing Date
2021-09-10
Accepted
2021-09-10 08:01:35
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROSPECTUS | ea147025-424b4_180lifesci.htm | 424B4 | 2733681
2 | GRAPHIC | image_001.jpg | GRAPHIC | 105237
3 | GRAPHIC | image_002.jpg | GRAPHIC | 53102
4 | GRAPHIC | image_003.jpg | GRAPHIC | 18163
5 | GRAPHIC | image_004.jpg | GRAPHIC | 41661
| Complete submission text file | 0001213900-21-047306.txt |  | 3035693

Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-259209 | Film No.: 211245887
SIC: 2834 Pharmaceutical Preparations